Group Tytgat

Medicijnen en Levenswetenschappen

1. Neuroblastoma 100%
2. Pediatrics 31%
3. Neoplasms 28%
4. Liquid Biopsy 20%
5. 3-Iodobenzylguanidine 20%
6. Wilms Tumor 17%
7. Child 16%
8. Cell-Free Nucleic Acids 14%
9. Immunotherapy 14%
10. Bone Marrow 13%
11. ch14.18 monoclonal antibody 11%
12. Netherlands 11%
13. Renal Cell Carcinoma 11%
14. Residual Neoplasm 11%
15. Kidney 10%
16. Progression-Free Survival 9%
17. Organoids 9%
18. Therapeutics 9%
19. Biomarkers 8%
20. 3-methoxytyramine 7%
21. Survival 7%
22. Bone Marrow Diseases 6%
23. Rhabdomyosarcoma 6%
24. Catecholamines 6%
25. Mesenchymal Stem Cells 6%
26. Neutrophils 5%
27. Messenger RNA 5%
28. Recurrence 5%
29. Precursor Cell Lymphoblastic Leukemia-Lymphoma 5%
30. Polymerase Chain Reaction 5%
31. Extracellular Vesicles 5%
32. Systematic Reviews 5%
33. Drug Therapy 5%
34. Positron-Emission Tomography 5%